GNOM
EquitiesGlobalThematicAccumulating
Global X Genomics & Biotechnology UCITS ETF
It tracks the Solactive Genomics index with 50 genomics and biotechnology companies. This is a research driven field with large swings and a heavy weight in the United States.
Key facts
- ISIN
- IE00BM8R0N95
- Provider
- Global X
- Index
- Solactive Genomics
- TER (annual cost)
- 0.50%
- Replication
- Physical (full)
- Distributions
- Accumulating
- Domicile
- Ireland
- Base currency
- USD
- Launch year
- 2021
- Fund size (approx.)
- ~€0.05bn
Listings
| Exchange | Ticker |
|---|---|
| Xetra | GN0M |
| gettex | GN0M |
| Borsa Italiana | GNOM |
| London Stock Exchange | GNOM |
| SIX Swiss Exchange | GNOM |
Related articles from the blog
Dollar Cost Averaging (DCA)ETFs
What are thematic ETFs and are they worth having in your portfolio?
From AI and clean energy to biotechnology: investing in trends or a hype trap?
16 min read
Dollar Cost Averaging (DCA)ETFs
How to build a resilient portfolio
For investors who want to build something stable, simple and rewarding over the long term.
18 min read
Dollar Cost Averaging (DCA)ETFs
What is an ETF? A complete beginner's guide
Learn how ETFs work, why they have become so popular and how you can use them to invest with strategy.
23 min read
Data as of September 2026, refreshed periodically. This content is for information only and is not investment advice or a recommendation. Verify the official documents (KID/prospectus) with the provider before any decision.